The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading medicinal cannabis company and Biofloral Inc, a Canadian east coast hydroponics company, have chosen to work together to benefit from each other's IP and distribution networks. The proposed acquisition of BioFloral (ASX- 24 January 2018) is not proceeding.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides a summary of the outlook for each of its cannabis sector investments through to the end of this year.
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis company provides the enclosed Company Presentation updated to July 2018 in accordance with ASX Listing Rule 3.1.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to announce results of the Phase 2 clinical trial undertaken by its wholly-owned subsidiary PhytoTech Therapeutics Ltd. As previously announced, PTL is to be sold by MMJ to Harvest One Cannabis Inc. (CVE:HVT), subject to MMJ shareholder approval.
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis company advises that the conditions precedent have been met for the lease of a Northern NSW property to be used for the growing of medicinal cannabis strains as a primary source for its own manufacture within its Southport manufacturing facility.
Oventus Medical Ltd (ASX:OVN) announces its Appendix 4C Report for the three-month period ending 30 June 2018 (Q4 FY2018) and is pleased to provide a review of progress made during the quarter.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides an update on its current portfolio metrics.
